Brain Communications · 2021 · 25 citations · 37 references
MedicineNeurobiologyNeuroscienceMaternal-fetal MedicineNeurodegenerationSheep MedicineHypoxic-ischemic Brain InjuryHypoxic-ischemic EncephalopathyNeuroprotectionCaspase-mediated ApoptosisCerebral Hypoxic-ischemic InjuryCerebral Ischemia NeuroprotectionHypothermiaHypothermia TreatmentNeural IschemiaPerinatal Hypoxic-ischemic EncephalopathyWhite Matter Pathology
Abstract Therapeutic hypothermia for hypoxic-ischaemic encephalopathy provides partial white matter protection. Recombinant erythropoietin reduces demyelination after hypoxia-ischaemia, but it is unclear whether adjunct erythropoietin treatment can further improve outcomes after therapeutic hypothermia. Term-equivalent fetal sheep received sham-ischaemia (n = 9) or cerebral ischaemia for 30 min (ischaemia-vehicle, n = 8), followed by intravenous infusion of recombinant erythropoietin (ischaemia-Epo, n = 8; 5000 IU/kg bolus dose, then 833.3 IU/kg/h), cerebral hypothermia (ischaemia-hypothermia, n = 8), or recombinant erythropoietin plus hypothermia (ischaemia-Epo-hypothermia, n = 8), from 3 to 72 h post-ischaemia. Foetal brains were harvested at 7 days after cerebral ischaemia. Ischaemia was associated with marked loss of total Olig2-positive oligodendrocytes with reduced density of myelin and linearity of the white matter tracts (P < 0.01), and microglial induction and increased caspase-3-positive apoptosis. Cerebral hypothermia improved the total number of oligodendrocytes and restored myelin basic protein (P < 0.01), whereas recombinant erythropoietin partially improved myelin basic protein density and tract linearity. Both interventions suppressed microgliosis and caspase-3 (P < 0.05). Co-treatment improved 2′,3′-cyclic-nucleotide 3′-phosphodiesterase-myelin density compared to hypothermia, but had no other additive effect. These findings suggest that although hypothermia and recombinant erythropoietin independently protect white matter after severe hypoxia-ischaemia, they have partially overlapping anti-inflammatory and anti-apoptotic effects, with little additive benefit of combination therapy.
37
Neuroprotection With Prolonged Head Cooling Started Before Postischemic Seizures in Fetal Sheep
Alistair J. Gunn, Tania R. Gunn, Mark Gunning et al. · PEDIATRICS · 1998 · 326 citations
Medicine, Neurobiology, Neuroscience +15
A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants
Sandra E. Juul, Bryan A. Comstock, Rajan Wadhawan et al. · New England Journal of Medicine · 2020 · 322 citations · Full text
Medicine, Neuroscience, Pediatrics +14